Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867899-25-000005
Filing Date
2025-10-01
Accepted
2025-10-01 16:44:52
Documents
1
Period of Report
2025-09-29

Document Format Files

Seq Description Document Type Size
1 form4-10012025_081048.html 4  
1 form4-10012025_081048.xml 4 7522
  Complete submission text file 0001867899-25-000005.txt   9163
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KINIKSA PHARMACEUTICALS LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Tessari Eben (Reporting) CIK: 0001867899 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 251365209